<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>4</Volume><Issue>5</Issue><PubDate PubStatus="epublish"><Year>2012</Year><Month>04</Month><Day>02</Day></PubDate></Journal><title locale="en_US">Vitamin D3 Concentration Correlates with the Severity of Multiple Sclerosis</title><FirstPage>585</FirstPage><LastPage>591</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Jondishapour Neurology Clinic, Shaheed Beheshti University of Medical Sciences and Health Services (SUMS), Tehran, Iran</affiliation></Author><Author><affiliation locale="en_US">Shaheed Beheshti University of Medical Sciences and Health Services (SUMS), Tehran, Iran</affiliation></Author><Author><affiliation locale="en_US">Firoozgar Clinical Research Development Center (FCRDC), Tehran University of Medical Sciences (TUMS), Tehran, Iran</affiliation></Author><Author><affiliation locale="en_US">Jondishapour Neurology Clinic, Tehran University of Medical Sciences (TUMS),Tehran, Iran</affiliation></Author><Author><affiliation locale="en_US">Tehran University of Medical Sciences (TUMS), Tehran, Iran</affiliation></Author><Author><affiliation locale="en_US">Jondishapour Neurology Clinic, Tehran, Iran</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2011</Year><Month>07</Month><Day>15</Day></PubDate><PubDate PubStatus="accepted"><Year>2012</Year><Month>03</Month><Day>13</Day></PubDate><PubDate PubStatus="revised"><Year>2012</Year><Month>02</Month><Day>18</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;strong&gt;Aims: &lt;/strong&gt;To investigate the possible association between serum 25(OH) vitamin D3 concentration and the severity of disease in Iranian patients with multiple sclerosis (MS) and to compare this concentration with a matched control group.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This was an analytical cross‑sectional study performed at Jondishapour Neurology Clinic in Tehran, Iran. Patients with relapsing&amp;ndash; remitting MS were categorized by disease severity: mild [0&amp;le; Expanded Disability Status Scale (EDSS) &amp;le;3], moderate (3.5&amp;le;EDSS&amp;le;5.5), and severe (6&amp;le;EDSS). Serum concentrations of 25(OH) vitamin D3, calcium, phosphorus, magnesium, and parathyroid hormone were measured in 98 MS patients and 17 healthy age‑ and sex‑matched controls. Fisher&amp;rsquo;s exact, Kruskal&amp;ndash;Wallis, Mann&amp;ndash;Whitney &lt;em&gt;U &lt;/em&gt;test, and independent &lt;em&gt;t &lt;/em&gt;and Spearman rank correlation tests were used.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Serum 25(OH) vitamin D3 concentration was significantly lower in patients with MS, especially in the severe MS subgroup, compared with healthy controls (&lt;em&gt;P&lt;/em&gt;=0.047). There was a statistically significant inverse correlation between 25(OH) vitamin D3 concentration and EDSS score (&lt;em&gt;P&lt;/em&gt;=0.049, &lt;em&gt;R=&lt;/em&gt;&amp;ndash;0.168 by Spearman rank correlation test), which was observed in women only (&lt;em&gt;P&lt;/em&gt;=0.044, &lt;em&gt;R&lt;/em&gt;=&amp;ndash;0.199).&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Our findings not only further disclose the lower level of vitamin D in MS patients in comparison with healthy controls, but also support the association between vitamin D and disease severity in MS.&lt;/p&gt; &lt;strong&gt;Key words: &lt;/strong&gt;25(OH) vitamin D3, disease severity, multiple sclerosis</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/261</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/261/1038</pdf_url></Article></Articles>
